Webfeb 2, 2023 · gsk chief executive officer emma walmsley warned the u. k.

Websep 18, 2023 · gsk’s senior vice president and head of research john lepore, m. d. , has left the company at the same time the u. k.

It is believed about 200 roles will be cut at the facility in barnard castle,.

Recommended for you

The acquisition closed in june 2023 and centered around a p2x3.

Pharma undergoes a slight shuffling of its r&d operations.

Is at a “tipping point” and risks falling short of government ambitions to become a life sciences.

You may also like